Related Experiment Video

Updated: Jun 18, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

17.4K

Proceedings from The Consortium for Technology & Innovation in Pediatrics (CTIP) 2024 Annual Pediatric Device

Tamara P Lambert1, Grzegorz Zapotoczny1,2, Bianca Riello3

  • 1Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.

BMC Proceedings
|March 24, 2025
PubMed

Insights

The CTIP symposium convened stakeholders to advance pediatric medical device (PMD) innovation. Discussions focused on R&D, patient engagement, and investment to improve pediatric healthcare technologies.

Area of Science:

  • Biomedical Engineering
  • Healthcare Innovation
  • Pediatric Medicine

Background:

  • Pediatric medical devices (PMDs) face unique innovation challenges.
  • Stakeholder collaboration is crucial for advancing pediatric healthcare technology.

Purpose of the Study:

  • To summarize the proceedings of the CTIP symposium on pediatric medical device innovation.
  • To identify critical needs, challenges, and opportunities in the PMD sector.
  • To outline collaborative strategies for driving PMD development.

Main Methods:

  • A summary of discussions from the CTIP symposium held on August 9, 2024.
  • Key topics included the future of pediatric innovation, patient engagement, R&D partnerships, real-world evidence, and investment.

Main Results:

  • Identified critical needs and challenges in pediatric medical device development.
  • Highlighted opportunities for stakeholder collaboration.
  • Emphasized the importance of patient and family engagement in the design process.

Conclusions:

  • Collective action among stakeholders is essential to accelerate pediatric medical device innovation.
  • Strategic partnerships and investment are key to overcoming R&D hurdles.
  • Leveraging real-world evidence can enhance the efficacy and safety of PMDs.

Keywords:
FDAInnovationMedical device developmentPMDPediatric medical devicesPediatricsProceedingsUnited States Food and Drug Administration

More Related Videos

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.1K
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

49.5K

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...